Diclofenac Sodium Tablet, Delayed Release
Product Images NDC 82868-101

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 82868-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (82868 101 90 Rev A 02 26 Nhc)

Label (82868 101 90   Rev A 02 26 Nhc)
Label for Diclofenac Sodium Delayed-Release Tablets, USP 50 mg, containing 90 tablets. The label includes storage instructions to keep at 20°-25°C (68°-77°F) and to keep the container tightly closed. It also notes the product is prescription only and manufactured by Northwind Health Company, LLC. Packaging indicates the presence of enteric-coated tablets.*
FDA Label Image

Chemical Structure (Diclofenac Str)

Chemical Structure (Diclofenac Str)
Chemical structure of diclofenac sodium showing the molecular arrangement including two chlorinated benzene rings connected via an amino group and a sodium carboxylate substituent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.